Patents by Inventor Latifa Dahricorreia

Latifa Dahricorreia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
    Patent number: 7101863
    Abstract: The invention concerns pharmaceutical compositions with wound healing or anti-complementary activity, and their uses, said compositions comprising, (1) at least a dextran derivative of general formula DMCaBbSuc, a, b, and c respectively representing the degrees of substitution in the groups MC, B and Su, wherein a?0.6, b=0 or ?0.1, and c=0 or ranges widely between 0.1 and 0.5 for a wound healing composition, and a?0.3, b?0.1 and c=0 or ranges widely between 0.1 and 0.4 for a composition with anti-complementary activity; (2) and at least a pharmaceutically acceptable carrier, said dextran derivative being present in a single unit dose or at a concentration adapted to the desired wound healing or anti-complementary activity.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: September 5, 2006
    Assignee: Biodex
    Inventors: Latifa Dahricorreia, Jacqueline Jozefonvicz, Marcel Jozefowicz, José Correia, Rémi Huynh
  • Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
    Publication number: 20020183282
    Abstract: The invention concerns pharmaceutical compositions with wound healing or anti-complementary activity, and their uses, said compositions comprising. (1) at least a dextran derivative of general formula DMCaBbSuc, a, b, and c respectively representing the degrees of substitution in the groups MC, B and Su, wherein a ≧0.6, b=0 or ≧0.1, and c=0 or ranges widely between 0.1 and 0.5 for a wound healing composition, and a≧0.3, b ≧0.1 and c=0 or ranges widely between 0.1 and 0.4 for a composition with anti-complementary activity; (2) and at least a pharmaceutically acceptable carrier, said dextran derivative being present in a single unit dose or at a concentration adapted to the desired wound healing or anti-complementary activity.
    Type: Application
    Filed: December 13, 2001
    Publication date: December 5, 2002
    Inventors: Latifa Dahricorreia, Jacqueline Jozefonvicz, Marcel Jozefowicz, Jose Correia, Remi Huynh